Nutrition Assessment and Monitoring and Evaluation Terminology

This is a combined list of Nutrition Assessment and Monitoring and Evaluation terms. Shaded indicators are used ONLY for nutrition assessment. All of the other
indicators are used for both assessment and monitoring and evaluation. Each term is designated with an alpha-numeric NCPT hierarchical code, followed by a five-digit
(e.g., 99999) Academy SNOMED CT/LOINC unique identifier (ANDUID). Neither should be used in nutrition documentation. The ANDUID is for data tracking
purposes in electronic health records.
NCPT Code ANDUID NCPT Code ANDUID
 
FOOD/NUTRITION-RELATED HISTORY (FH) q Food additive intake (specify) FH-1.4.2.6 10038
Food and nutrient intake, food and nutrient administration, medication and q Other (specify) FH-1.4.2.7 10039
complementary/alternative medicine use, knowledge/beliefs/attitudes, behavior, food and Caffeine intake (1.4.3)
supply availability, physical activity and function, nutrition-related patient/client-centered
measures. q Total caffeine intake FH-1.4.3.1 10041

Food and Nutrient Intake (1) Macronutrient Intake (1.5)

Composition and adequacy of food and nutrient intake, meal and snack patterns, current
and previous diets and/or food modifications, and eating environment.
Energy Intake (1.1)
Fat and cholesterol, protein, carbohydrate, and fiber intake from all sources including
food, beverages, supplements, and via enteral and parenteral routes.
Fat intake (1.5.1)

Total energy intake from all sources including food, beverages, breastmilk/formula, q Total fat intake FH-1.5.1.1 10044
supplements, and via enteral and parenteral routes. q Saturated fat intake FH-1.5.1.2 10045
Energy intake (1.1.1) q Trans fatty acid intake FH-1.5.1.3 10046
q Total energy intake FH-1.1.1.1 10005 q Polyunsaturated fat intake FH-1.5.1.4 10047
Food and Beverage Intake (1.2) q Linoleic acid intake FH-1.5.1.4.1 11602
Type, amount, and pattern of intake of foods and food groups, indices of diet quality, q Monounsaturated fat intake FH-1.5.1.5 10048
intake of fluids, breastmilk and infant formula q Omega-3 fatty acid intake FH-1.5.1.6 10049
Fluid/beverage intake (1.2.1) q Alphalinolenic acid intake FH-1.5.1.6.1 11603
q Oral fluids FH-1.2.1.1 10008 q Eicosapentaenoic acid intake FH-1.5.1.6.2 11604
q Food-derived fluids FH-1.2.1.2 10009 q Docosahexaenoic acid intake FH-1.5.1.6.3 11605
q Liquid meal replacement or supplement FH-1.2.1.3 10010 q Essential fatty acid intake FH-1.5.1.7 10051
Food intake (1.2.2) q Medium chain triglyceride intake FH-1.5.1.8 11606
q Amount of food FH-1.2.2.1 10012 Cholesterol intake (1.5.2)
q Types of food/meals FH-1.2.2.2 10013 q Dietary cholesterol intake FH-1.5.2.1 10050
q Meal/snack pattern FH-1.2.2.3 10014 Protein intake (1.5.3)
q Diet quality index FH-1.2.2.4 10015 q Total protein intake FH-1.5.3.1 10053
q Food variety FH-1.2.2.5 10016 q High biological value protein intake FH-1.5.3.2 10054
Breastmilk/infant formula intake (1.2.3) q Casein intake FH-1.5.3.3 10055
q Breastmilk intake FH-1.2.3.1 10018 q Whey intake FH-1.5.3.4 10056
q Infant formula intake FH-1.2.3.2 10019 q Gluten intake FH-1.5.3.5 11609
Enteral and Parenteral Nutrition Intake (1.3) q Natural protein intake FH-1.5.3.6 11610
Specialized nutrition support intake from all sources, e.g., enteral and parenteral routes. Amino acid intake (1.5.4)
Enteral nutrition intake (1.3.1) q Total amino acid intake FH-1.5.4.1 10057
q Enteral nutrition formula/solution FH-1.3.1.1 10022 q Essential amino acid intake FH-1.5.4.2 10058

q Feeding tube flush FH-1.3.1.2 10023 q Histidine intake FH-1.5.4.2.1 11612

Parenteral nutrition intake (1.3.2) q Methionine intake FH-1.5.4.2.2 11613

q Isoleucine intake FH-1.5.4.2.3 11614
q Parenteral nutrition formula/solution FH-1.3.2.1 10025
q Leucine intake FH-1.5.4.2.4 11615
q IV fluids FH-1.3.2.2 10026
q Lysine intake FH-1.5.4.2.5 11616
Bioactive Substance Intake (1.4)
q Threonine intake FH-1.5.4.2.6 11617
Alcohol, plant stanol and sterol esters, soy protein, psyllium and b-glucan, and caffeine
intake from all sources, e.g., food, beverages, supplements, and via enteral and parenteral q Tryptophan intake FH-1.5.4.2.7 11618
routes. q Phenylalanine intake FH-1.5.4.2.8 11619
Alcohol intake (1.4.1) q Valine intake FH-1.5.4.2.9 11620
q Drink size/volume FH-1.4.1.1 10029 q Nonessential amino acid intake FH-1.5.4.3 11621
q Frequency FH-1.4.1.2 10030 q Arginine intake FH-1.5.4.3.1 11622

q Pattern of alcohol consumption FH-1.4.1.3 10031 q Glutamine intake FH-1.5.4.3.2 11623

Bioactive substance intake (1.4.2) q Homocysteine intake FH-1.5.4.3.3 11624

q Tyramine intake FH-1.5.4.3.4 11625
q Plant stanol ester intake FH-1.4.2.1 10034
q Tyrosine intake FH-1.5.4.3.5 11626
q Plant sterol ester intake FH-1.4.2.2 10807
Carbohydrate intake (1.5.5)
q Soy protein intake FH-1.4.2.3 10035
q Total carbohydrate intake FH-1.5.5.1 10060
q Psyllium intake FH-1.4.2.4 10827
q Complex carbohydrate intake FH-1.5.5.2 11627
q β-glucan intake FH-1.4.2.5 10037
q Simple sugar carbohydrate intake FH-1.5.5.3 11628

1
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Galactose intake FH-1.5.5.4 11629 Food and Nutrient Administration (2)
q Lactose intake FH-1.5.5.5 11630 Current and previous diets and/or food modifications, eating environment, and enteral and
q Fructose intake FH-1.5.5.6 11631 parenteral nutrition administration.
q Glycemic index FH-1.5.5.7 10063 Diet History (2.1)
q Glycemic load FH-1.5.5.8 10064 Description of food and drink regularly provided or consumed, past diets followed or
prescribed and counseling received, and the eating environment.
q Source of carbohydrate FH-1.5.5.9 10065
Diet order (2.1.1)
q Insulin-to-carbohydrate ratio FH-1.5.5.10 10066
q General, healthful diet order FH-2.1.1.1 10113
Fiber intake (1.5.6)
q Modified diet order FH-2.1.1.2 10114
q Total fiber intake FH-1.5.6.1 10068
q Enteral nutrition order FH-2.1.1.3 10115
q Soluble fiber intake FH-1.5.6.2 10069
q Parenteral nutrition order FH-2.1.1.4 10116
q Insoluble fiber intake FH-1.5.6.3 10070
Diet experience (2.1.2)
Micronutrient Intake (1.6)
q Previously prescribed diets FH-2.1.2.1 10118
Vitamin and mineral intake from all sources including food, beverages, supplements, and
via enteral and parenteral routes. q Previous diet/nutrition education/counseling FH-2.1.2.2 10119

Vitamin intake (1.6.1) q Self-selected diet/s followed FH-2.1.2.3 10120

q A (1) 10073 q Dieting attempts FH-2.1.2.4 10121

q C (2) 10074 q Food allergies FH-2.1.2.5 10805

q D (3) 10075 q Food intolerance FH-2.1.2.6 10806

q E (4) 10076 Eating environment (2.1.3)

q K (5) 10077 q Location FH-2.1.3.1 10123

q Atmosphere FH-2.1.3.2 10124
q Thiamin (6) 10078
q Caregiver/companion FH-2.1.3.3 10125
q Riboflavin (7) 10079
q Appropriate breastfeeding FH-2.1.3.4 10126
q Niacin (8) 10080
accommodations/facility
q Folate (9) 10081 q Eats alone FH-2.1.3.5 10127
q B6 (10) 10082 Enteral and parenteral nutrition administration (2.1.4)
q B12 (11) 10083 q Enteral access FH-2.1.4.1 10129
q Pantothenic acid (12) 10084 q Parenteral access FH-2.1.4.2 10130
q Biotin (13) 10085 q Body position, EN FH-2.1.4.3 10804
q Multivitamin (14) 10086 Fasting (2.1.5)
Mineral/element intake (1.6.2) q Fasting pattern in one calendar day, reported FH-2.1.5.1 11633
q Calcium (1) 10089 q Fasting pattern in one calendar week, reported FH-2.1.5.2 11634

q Chloride (2) 10090 q Fasting pattern in one calendar month, reported FH-2.1.5.3 11635
q Fasting pattern in one calendar year, reported FH-2.1.5.4 11636
q Iron (3) 10091
q Fasting tolerance, reported FH-2.1.5.5 11637
q Magnesium (4) 10092
Medication and Complementary/Alternative Medicine Use (3)
q Potassium (5) 10093
Prescription and over-the-counter medications, including herbal preparations and
q Phosphorus (6) 10094 complementary/alternative medicine products used.
q Sodium (7) 10095 Medications (3.1)
q Zinc (8) 10096 q Prescription medication use FH-3.1.1 10820
q Sulfate (9) 10097 q OTC medication use FH-3.1.2 10134
q Fluoride (10) 10098 q Misuse of medication FH-3.1.3 10135

q Copper (11) 10099 Complementary/Alternative Medicine (3.2)

q Iodine (12) 10100 q Nutrition-related complementary/alternative FH-3.2.1 10137
medicine use
q Selenium (13) 10101
Knowledge/Beliefs/Attitudes (4)
q Manganese (14) 10102
Understanding of nutrition-related concepts and conviction of the truth and
q Chromium (15) 10103 feelings/emotions toward some nutrition-related statement or phenomenon, along with
q Molybdenum (16) 10104 readiness to change nutrition-related behaviors.

q Boron (17) 10105 Food and nutrition knowledge/skill (4.1)

q Cobalt (18) 10106 q Area(s) and level of knowledge/skill FH-4.1.1 10848

q Diagnosis specific or global nutrition-related FH-4.1.2 10143
q Multi-mineral (19) 10107
knowledge score
q Multi-trace element (20) 10108
Beliefs and attitudes (4.2)

2
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Conflict with personal/family value system FH-4.2.1 10145 q Availability of shopping facilities FH-6.2.1 10192
q Distorted body image FH-4.2.2 10146 q Procurement of safe food FH-6.2.2 10800
q End-of-life decisions FH-4.2.3 10147 q Appropriate meal preparation facilities FH-6.2.3 10194
q Motivation FH-4.2.4 10148 q Availability of safe food storage FH-6.2.4 10195
q Preoccupation with food/nutrients FH-4.2.5 10149 q Appropriate storage technique FH-6.2.5 10196
q Preoccupation with weight FH-4.2.6 10150 q Identification of safe food FH-6.2.6 10801
q Readiness to change nutrition-related behaviors FH-4.2.7 10151 Safe water availability (6.3)
q Self-efficacy FH-4.2.8 10152 q Availability of potable water FH-6.3.1 10198
q Self-talk/cognitions FH-4.2.9 10153 q Appropriate water decontamination FH-6.3.2 10199
q Unrealistic nutrition-related goals FH-4.2.10 10154 Food and nutrition-related supplies availability (6.4)
q Unscientific beliefs/attitudes FH-4.2.11 10155 q Access to food and nutrition-related supplies FH-6.4.1 10201
q Food preferences FH-4.2.12 10156 q Access to assistive eating devices FH-6.4.2 10202
q Emotions FH-4.2.13 10157 q Access to assistive food preparation devices FH-6.4.3 10203
Behavior (5) Physical Activity and Function (7)
Patient/client activities and actions, which influence achievement of nutrition-related Physical activity, cognitive and physical ability to engage in specific tasks, e.g.,
goals. breastfeeding and self-feeding.

Adherence (5.1) Breastfeeding (7.1)

q Self-reported adherence score FH-5.1.1 10160 q Initiation of breastfeeding FH-7.1.1 10206

q Nutrition visit attendance FH-5.1.2 10161 q Duration of breastfeeding FH-7.1.2 10207

q Ability to recall nutrition goals FH-5.1.3 10162 q Exclusive breastfeeding FH-7.1.3 10208

q Self-monitoring at agreed upon rate FH-5.1.4 10163 q Breastfeeding problems FH-7.1.4 10209

q Self-management as agreed upon FH-5.1.5 10164 Nutrition-related ADLs and IADLs (7.2)
Avoidance behavior (5.2) q Physical ability to complete tasks for meal FH-7.2.1 10211
preparation
q Avoidance FH-5.2.1 10166
q Physical ability to self-feed FH-7.2.2 10212
q Restrictive eating FH-5.2.2 10167
q Ability to position self in relation to plate FH-7.2.3 10213
q Cause of avoidance behavior FH-5.2.3 10168
q Receives assistance with intake FH-7.2.4 10214
Bingeing and purging behavior (5.3)
q Ability to use adaptive eating devices FH-7.2.5 10215
q Binge eating behavior FH-5.3.1 10170
q Cognitive ability to complete tasks for meal FH-7.2.6 10216
q Purging behavior FH-5.3.2 10171
preparation
Mealtime behavior (5.4)
q Remembers to eat FH-7.2.7 10139
q Meal duration FH-5.4.1 10173
q Recalls eating FH-7.2.8 10218
q Percent of meal time spent eating FH-5.4.2 10174
q Mini Mental State Examination Score FH-7.2.9 10219
q Preference to drink rather than eat FH-5.4.3 10175
q Nutrition-related activities of daily living (ADL) FH-7.2.10 10220
q Refusal to eat/chew FH-5.4.4 10176 score
q Spitting food out FH-5.4.5 10177 q Nutrition-related instrumental activities of daily FH-7.2.11 10221
q Rumination FH-5.4.6 10178 living (IADL) score

q Patient/client/caregiver fatigue during feeding FH-5.4.7 10179 Physical activity (7.3)

process resulting in inadequate intake q Physical activity history FH-7.3.1 10223
q Willingness to try new foods FH-5.4.8 10180 q Consistency FH-7.3.2 10224
q Limited number of accepted foods FH-5.4.9 10181 q Frequency FH-7.3.3 10225

q Rigid sensory preferences FH-5.4.10 10182 q Duration FH-7.3.4 10226

Social network (5.5) q Intensity FH-7.3.5 10227

q Ability to build and utilize social network FH-5.5.1 10184 q Type of physical activity FH-7.3.6 10228
q Strength FH-7.3.7 10229
Factors Affecting Access to Food and Food/Nutrition-Related
Supplies (6) q TV/screen time FH-7.3.8 10230

Factors that affect intake and availability of a sufficient quantity of safe, healthful food as q Other sedentary activity time FH-7.3.9 10231
well as food/nutrition-related supplies. q Involuntary physical movement FH-7.3.10 10232
Food/nutrition program participation (6.1) q Non exercise activity thermogenesis FH-7.3.11 10233

q Eligibility for government programs FH-6.1.1 10187 Factors affecting access to physical activity (7.4)
q Participation in government programs FH-6.1.2 10188 q Neighborhood safety FH-7.4.1 10822

q Eligibility for community programs FH-6.1.3 10189 q Walkability of neighborhood FH-7.4.2 10823
q Proximity to parks/green space FH-7.4.3 10824
q Participation in community programs FH-6.1.4 10190
q Access to physical activity facilities/programs FH-7.4.4 10825
Safe food/meal availability (6.2)
3
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
Nutrition-Related Patient/Client-Centered Measures (8) q Prothrombin time, PT BD-1.4.9 10279
Patient/client’s perception of his or her nutrition intervention and its impact on life. q Partial thromboplastin time, PTT BD-1.4.10 10280
Nutrition quality of life (8.1) q INR (ratio) BD-1.4.11 10281
q Nutrition quality of life responses FH-8.1.1 10236 q Amylase BD-1.4.12 10283
q Lipase BD-1.4.13 10284
q Fecal fat, 24 hour BD-1.4.14 11242
ANTHROPOMETRIC MEASUREMENTS (AD)
q Fecal fat, 72 hour BD-1.4.15 11243
Height, weight, body mass index (BMI), growth pattern indices/percentile ranks, and
weight history. q Fecal fat, qualitative BD-1.4.16 11244

Body composition/growth/weight history (1.1) q Fecal calprotectin BD-1.4.17 11245

q Height/length AD-1.1.1 10239 q Fecal lactoferrin BD-1.4.18 11246

q Weight AD-1.1.2 10240 q Pancreatic elastase BD-1.4.19 11150

q Frame size AD-1.1.3 10241 q 5'nucleotidase BD-1.4.20 11247

q Weight change AD-1.1.4 10242 q D-xylose BD-1.4.21 10286

q Body mass index AD-1.1.5 10243 q Lactulose hydrogen breath test BD-1.4.22 11248

q Growth pattern indices/percentile ranks AD-1.1.6 10244 q Lactose hydrogen breath test BD-1.4.23 11249

q Body compartment estimates AD-1.1.7 10245 q Fructose hydrogen breath test BD-1.4.24 11250
q Glucose hydrogen breath test BD-1.4.25 11251
q Urea hydrogen breath test BD-1.4.26 11252
BIOCHEMICAL DATA, MEDICAL TESTS AND PROCEDURES (BD)
q Intestinal biopsy BD-1.4.27 10288
Laboratory data, (e.g., electrolytes, glucose, and lipid panel) and tests (e.g., gastric
emptying time, resting metabolic rate). q Stool culture BD-1.4.28 10289

Acid-base balance (1.1) q Gastric emptying time BD-1.4.29 10290

q Small bowel transit time BD-1.4.30 10291
q Arterial pH BD-1.1.1 10248
q Abdominal X-ray BD-1.4.31 11253
q Arterial bicarbonate BD-1.1.2 10249
q Abdominal CT BD-1.4.32 11254
q Partial pressure of carbon dioxide in arterial BD-1.1.3 10250
blood, PaCO2 q Abdominal ultrasound BD-1.4.33 11255
q Partial pressure of oxygen in arterial blood, BD-1.1.4 10251 q Endoscopic ultrasound BD-1.4.34 11256
PaO2 q Pelvic CT BD-1.4.35 11257
q Venous pH BD-1.1.5 10252 q Modified barium swallow BD-1.4.36 11258
q Venous bicarbonate BD-1.1.6 10253 q Barium swallow BD-1.4.37 11259
Electrolyte and renal profile (1.2) q Esophagogastroduodenoscopy BD-1.4.38 11260
q BUN BD-1.2.1 10255 q ERCP BD-1.4.39 11261
q Creatinine BD-1.2.2 10256 q Capsule endoscopy BD-1.4.40 11262
q BUN:creatinine ratio BD-1.2.3 10257 q Esophageal manometry BD-1.4.41 11263
q Glomerular filtration rate BD-1.2.4 10258 q Esophageal pH test BD-1.4.42 11264
q Sodium BD-1.2.5 10259 q Gastroesophageal reflux monitoring BD-1.4.43 11265
q Chloride BD-1.2.6 10260 q Gastrointestinal sphincter monitoring BD-1.4.44 11266
q Potassium BD-1.2.7 10261 q Urate BD-1.4.45 11638
q Magnesium BD-1.2.8 10262 Glucose/endocrine profile (1.5)
q Calcium, serum BD-1.2.9 10263 q Glucose, fasting BD-1.5.1 10295
q Calcium, ionized BD-1.2.10 10264 q Glucose, casual BD-1.5.2 10296
q Phosphorus BD-1.2.11 10265 q HgbA1c BD-1.5.3 10297
q Serum osmolality BD-1.2.12 10266 q Preprandial capillary plasma glucose BD-1.5.4 10298
q Parathyroid hormone BD-1.2.13 10267 q Peak postprandial capillary plasma glucose BD-1.5.5 10299
Essential fatty acid profile (1.3) q Glucose tolerance test BD-1.5.6 10300
q Triene:Tetraene ratio BD-1.3.1 10269 q Cortisol level BD-1.5.7 10301
Gastrointestinal profile (1.4) q IGF-binding protein BD-1.5.8 10302
q Alkaline phosphatase BD-1.4.1 10271 q Thyroid stimulating hormone BD-1.5.9 11639
q Alanine aminotransferase, ALT BD-1.4.2 10272 q Thyroxine test BD-1.5.10 11640
q Aspartate aminotransferase, AST BD-1.4.3 10273 q Triiodothyronine BD-1.5.11 11641
q Gamma glutamyl transferase, GGT BD-1.4.4 10274 q Adrenocorticotropic hormone BD-1.5.12 11642
q Gastric residual volume BD-1.4.5 10275 q Follicle stimulating hormone BD-1.5.13 11643
q Bilirubin, total BD-1.4.6 10276 q Growth hormone BD-1.5.14 11644
q Ammonia, serum BD-1.4.7 10277 q Luteinizing hormone BD-1.5.15 11645
q Toxicology report, including alcohol BD-1.4.8 10278 Inflammatory profile (1.6)

4
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q C-reactive protein BD-1.6.1 10305 q Alanine BD-1.11.18 11162
Lipid profile (1.7) q Citrulline BD-1.11.19 11163
q Cholesterol, serum BD-1.7.1 10307 q Valine BD-1.11.20 11164
q Cholesterol, HDL BD-1.7.2 10308 q Cysteine BD-1.11.21 11165
q Cholesterol, LDL BD-1.7.3 10309 q Methionine BD-1.11.22 11166
q Cholesterol, non-HDL BD-1.7.4 10310 q Isoleucine BD-1.11.23 11167
q Total cholesterol:HDL cholesterol BD-1.7.5 10311 q Leucine BD-1.11.24 11168
q LDL:HDL BD-1.7.6 10312 q Ornithine BD-1.11.25 11169
q Triglycerides, serum BD-1.7.7 10313 q Lysine BD-1.11.26 11170
Metabolic rate profile (1.8) q Histidine BD-1.11.27 11171
q Resting metabolic rate, measured BD-1.8.1 10315 q Arginine BD-1.11.28 11172
q Respiratory quotient, measured BD-1.8.2 10316 q Lysine:arginine BD-1.11.29 11173
Mineral profile (1.9) q Tryptophan BD-1.11.30 11174
q Copper, serum or plasma BD-1.9.1 10318 q Plasma organic acid panel BD-1.11.31 11175
q Iodine, urinary excretion BD-1.9.2 10319 q Organic acids/creatinine BD-1.11.32 11176
q Zinc, serum or plasma BD-1.9.3 10320 q 3-hydroxybutyrate BD-1.11.33 11181
q Boron, serum or plasma BD-1.9.4 10841 q 3-hydroxyisovalerate BD-1.11.34 11182
q Chromium, serum or urinary BD-1.9.5 10842 q Acetoacetate BD-1.11.35 11183
q Fluoride, plasma BD-1.9.6 10843 q Ethylmalonate BD-1.11.36 11184
q Manganese, urinary, blood, plasma BD-1.9.7 10844 q Succinate BD-1.11.37 11185
q Molybdenum, serum BD-1.9.8 10845 q Fumarate BD-1.11.38 11186
q Selenium, serum or urinary BD-1.9.9 10846 q Glutarate BD-1.11.39 11187

Nutritional anemia profile (1.10) q 3-methylglutarate BD-1.11.40 11188

q Hemoglobin BD-1.10.1 10323 q Adipate BD-1.11.41 11189

q Hematocrit BD-1.10.2 10324 q 2-hydroxyglutarate BD-1.11.42 11190

q Mean corpuscular volume BD-1.10.3 10325 q 3-hydroxyphenylacetate BD-1.11.43 11191

q Red blood cell folate BD-1.10.4 10326 q 2-ketoglutarate BD-1.11.44 11192

q Red cell distribution width BD-1.10.5 10327 q Citrate BD-1.11.45 11193

q B12, serum BD-1.10.6 10328 q Propionate BD-1.11.46 11194

q Methylmalonic acid, serum BD-1.10.7 10329 q Methylcitrate BD-1.11.47 11195

q Folate, serum BD-1.10.8 10330 q 3-hydroxy propionate BD-1.11.48 11196

q Homocysteine, serum BD-1.10.9 10331 q β-hydroxy butyrate BD-1.11.49 11197

q Ferritin, serum BD-1.10.10 10332 q Creatine kinase BD-1.11.50 11198

q Iron, serum BD-1.10.11 10333 q Troponin I. cardiac BD-1.11.51 11199

q Total iron-binding capacity BD-1.10.12 10334 q Troponin T. cardiac BD-1.11.52 11200

q Transferrin saturation BD-1.10.13 10335 q B-type natriuretic peptide BD-1.11.53 11201

Protein profile (1.11) q Succinylacetone BD-1.11.54 11202

q Albumin BD-1.11.1 10337 q Total serum immunoglobulin A BD-1.11.55 11267

q Prealbumin BD-1.11.2 10338 q Tissue transglutaminase antibodies (IgA) BD-1.11.56 11268

q Transferrin BD-1.11.3 10339 q Tissue transglutaminase antibodies (IgG) BD-1.11.57 11269

q Phenylalanine, plasma BD-1.11.4 10340 q Deamidated gliadin peptide antibodies (IgG) BD-1.11.58 11270

q Tyrosine, plasma BD-1.11.5 10341 q Endomysial antibodies BD-1.11.59 11271

q Amino acid panel BD-1.11.6 10342 q Carbohydrate-deficient transferrin BD-1.11.60 10847

q Phenylalanine, dried blood spot BD-1.11.7 11151 Urine profile (1.12)

q Tyrosine, dried blood spot BD-1.11.8 11152 q Urine color BD-1.12.1 10345

q Phenylalanine:tyrosine BD-1.11.9 11153 q Urine osmolality BD-1.12.2 10346

q Hydroxyproline BD-1.11.10 11154 q Urine specific gravity BD-1.12.3 10347

q Threonine BD-1.11.11 11155 q Urine volume BD-1.12.4 10349

q Serine BD-1.11.12 11156 q Urine calcium, 24 hour BD-1.12.5 11272

q Asparagine BD-1.11.13 11157 q Urine d-xylose BD-1.12.6 11273

q Glutamate BD-1.11.14 11158 q Urine glucose BD-1.12.7 11203

q Glutamine BD-1.11.15 11159 q Urine ketones BD-1.12.8 11204

q Proline BD-1.11.16 11160 q Urine sodium BD-1.12.9 11205

q Glycine BD-1.11.17 11161 q Urine microalbumin BD-1.12.10 11206

5
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Urine protein, random BD-1.12.11 11207 q MCAD enzyme assay in fibroblasts or other BD-1.15.9 11238
q Urine protein, 24 hour BD-1.12.12 11208 tissues

q Urine uric acid, random BD-1.12.13 11209 q Fatty acid β-oxidation in fibroblasts BD-1.15.10 11239

q Urine uric acid, 24 hour BD-1.12.14 11210

q Urine organic acid panel BD-1.12.15 11211 NUTRITION-FOCUS PHYSICAL FINDINGS (PD)
q Urine glutarate BD-1.12.16 11212 Findings from a nutrition-focused physical exam, interview, or the medical record
q Urine methylmalonate BD-1.12.17 11213 including muscle and subcutaneous fat, oral health, suck/swallow/breathe ability, appetite,
and affect.
q Urine acylglycines/creatinine BD-1.12.18 11214
Nutrition-focused physical findings (1.1)
q Urine argininosuccinate BD-1.12.19 11215
q Overall findings (1)
q Urine succinylacetone/creatinine BD-1.12.20 11216
q Asthenia PD-1.1.1.1 11646
q Urine orotate BD-1.12.21 11217
q Buffalo hump PD-1.1.1.2 11647
q Urine orotate/creatinine BD-1.12.22 11218
q Cachexia PD-1.1.1.3 11648
q Urine 2-hydroxyisovalerate BD-1.12.23 11219
q Cushingoid appearance PD-1.1.1.4 11649
q Urine 2-oxoisovalerate BD-1.12.24 11220
q Ectomorph PD-1.1.1.5 11650
q Urine galactitol BD-1.12.25 11221
q Endomorph PD-1.1.1.6 11651
q Urine reducing substances BD-1.12.26 11222
q Lethargic PD-1.1.1.7 11652
q Urine porphyrins BD-1.12.27 11274
q Mesomorph PD-1.1.1.8 11653
Vitamin profile (1.13)
q Neglect of personal hygiene PD-1.1.1.9 11654
q Vitamin A, serum or plasma retinol BD-1.13.1 10351
q Obese PD-1.1.1.10 11655
q Vitamin C, plasma or serum BD-1.13.2 10352
q Short stature for age PD-1.1.1.11 11656
q Vitamin D, 25-hydroxy BD-1.13.3 10353
q Tall stature PD-1.1.1.12 11657
q Vitamin E, plasma alpha-tocopherol BD-1.13.4 10354
q Adipose (2)
q Thiamin, activity coefficient for erythrocyte BD-1.13.5 10355
transketolase activity q Atrophy of orbital fat PD-1.1.2.1 11659

q Riboflavin, activity coefficient for erythrocyte BD-1.13.6 10356 q Excess subcutaneous fat PD-1.1.2.2 11660
glutathione reductase activity q Loss of subcutaneous fat PD-1.1.2.3 11661
q Niacin, urinary N’methyl-nicotinamide BD-1.13.7 10357 q Central adiposity PD-1.1.2.4 11662
concentration q Bones (3)
q Vitamin B6, plasma or serum pyridoxal BD-1.13.8 10358 q Bow legs PD-1.1.3.1 11664
5’phosphate concentration
q Frontal bossing PD-1.1.3.2 11665
q Pantothenic acid, urinary pantothenate excretion, BD-1.13.9 10850
q Harrison’s sulcus PD-1.1.3.3 11666
plasma
q Rachitic rosary PD-1.1.3.4 11667
q Biotin, urinary 3-hydroxyisovaleric acid BD-1.13.10 11275
excretion q Rickets PD-1.1.3.5 11668
q Biotin, lymphocyte propionyl-CoA carboxylase BD-1.13.11 11276 q Scoliosis PD-1.1.3.6 11669
in pregnancy, serum q Cardiovascular-pulmonary system (4)
q Biotinidase BD-1.13.12 11223 q Absent breath sounds PD-1.1.4.1 11670
q Protein induced by vitamin K absence or BD-1.13.13 11224 q Bradycardia PD-1.1.4.2 11671
antagonist II q Bradypnea PD-1.1.4.3 11672
Carbohydrate metabolism profile (1.14) q Decreased breath sounds PD-1.1.4.4 11673
q Galactose-1-phosphate in red blood cell BD-1.14.1 11226 q Dyspnea PD-1.1.4.5 11674
q Galactose-1-phosphate uridyl transferase BD-1.14.2 11227 q Increased breath sounds PD-1.1.4.6 11675
q Fructose BD-1.14.3 11228 q Normal breath sounds PD-1.1.4.7 11676
q Lactate BD-1.14.4 11177 q Tachypnea PD-1.1.4.8 11677
q Pyruvate BD-1.14.5 11178 q Tachycardia PD-1.1.4.9 11678
q Lactate:pyruvate BD-1.14.6 11179 q Respiratory crackles PD-1.1.4.10 11679
Fatty acid profile (1.15) q Digestive system (5)
q Acylcarnitine panel BD-1.15.1 11230 q Abdominal bloating PD-1.1.5.1 11684
q Acylcarnitine, plasma BD-1.15.2 11231 q Abdominal cramping PD-1.1.5.2 11685
q Free carnitine BD-1.15.3 11232 q Abdominal distension PD-1.1.5.3 11686
q Total carnitine BD-1.15.4 11233 q Abdominal pain PD-1.1.5.4 11687
q Free carnitine:total carnitine BD-1.15.5 11234 q Absence of bowel sounds PD-1.1.5.5 11688
q Fatty acid panel mitochondrial C8-C18 BD-1.15.6 11235 q Anorexia PD-1.1.5.6 11689
q Fatty acid panel essential C12-C22 BD-1.15.7 11236 q Ascites PD-1.1.5.7 11690
q Fatty acid panel peroxisomal C22-C26 BD-1.15.8 11237 q Bulky stool PD-1.1.5.8 11691
q Constipation PD-1.1.5.9 11692

6
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Decrease in appetite PD-1.1.5.10 11693 q Joint arthralgia PD-1.1.7.21 11748
q Diarrhea PD-1.1.5.11 11694 q Lower limb spasticity PD-1.1.7.22 11749
q Early satiety PD-1.1.5.12 11695 q Peripheral cyanosis PD-1.1.7.23 11750
q Epigastric pain PD-1.1.5.13 11696 q Spasticity PD-1.1.7.24 11751
q Excessive appetite PD-1.1.5.14 11697 q Tetany PD-1.1.7.25 11752
q Excessive belching PD-1.1.5.15 11698 q Upper limb spasticity PD-1.1.7.26 11753
q Excessive flatus PD-1.1.5.16 11699 q Eyes (8)
q Fatty stool PD-1.1.5.17 11700 q Abnormal vision PD-1.1.8.1 11755
q Heartburn PD-1.1.5.18 11701 q Angular blepharitis PD-1.1.8.2 11756
q Hyperactive bowel sounds PD-1.1.5.19 11702 q Biotot’s spots PD-1.1.8.3 11757
q Hypoactive bowel sounds PD-1.1.5.20 11703 q Circles under eyes PD-1.1.8.4 11758
q Increased appetite PD-1.1.5.21 11704 q Corneal arcus PD-1.1.8.5 11759
q Liquid stool PD-1.1.5.22 11705 q Conjunctival discoloration PD-1.1.8.6 11760
q Loose stool PD-1.1.5.23 11706 q Conjunctival hemorrhage PD-1.1.8.7 11761
q Nausea PD-1.1.5.24 11707 q Conjunctival keratinization PD-1.1.8.8 11762
q Normal bowel sounds PD-1.1.5.25 11708 q Excessive tear production PD-1.1.8.9 11763
q Retching PD-1.1.5.26 11709 q Keratomalacia PD-1.1.8.10 11764
q Vomiting PD-1.1.5.27 11710 q Jaundiced sclera PD-1.1.8.11 11765
q Edema (6) q Night blindness PD-1.1.8.12 11766
q +1 pitting edema PD-1.1.6.1 11712 q Ophthalmoplegia PD-1.1.8.13 11767
q +2 pitting edema PD-1.1.6.2 11713 q Sunken eyes PD-1.1.8.14 11768
q +3 pitting edema PD-1.1.6.3 11714 q Xerophthalmia PD-1.1.8.15 11769
q +4 pitting edema PD-1.1.6.4 11715 q Xanthelasma PD-1.1.8.16 11770
q Anasarca PD-1.1.6.5 11716 q Genitourinary system (9)
q Ankle edema PD-1.1.6.6 11717 q Amenorrhea PD-1.1.9.1 11772
q Edema of calf PD-1.1.6.7 11718 q Anuria PD-1.1.9.2 11773
q Edema of eyelid PD-1.1.6.8 11719 q Delay in sexual development and/or puberty PD-1.1.9.3 11774
q Edema of foot PD-1.1.6.9 11720 q Menorrhagia PD-1.1.9.4 11775
q Edema of hand PD-1.1.6.10 11721 q Oliguria PD-1.1.9.5 11776
q Edema of scrotum PD-1.1.6.11 11722 q Polyuria PD-1.1.9.6 11777
q Edema of thigh PD-1.1.6.12 11723 q Hair (10)
q Edema of vulva PD-1.1.6.13 11724 q Abnormal keratinization of hair follicle PD-1.1.10.1 11779
q Mucosal edema PD-1.1.6.14 11725 q Alopecia PD-1.1.10.2 11780
q Sacral edema PD-1.1.6.15 11726 q Brittle hair PD-1.1.10.3 11781
q Extremities (7) q Corkscrew hairs PD-1.1.10.4 11782
q Amputated foot PD-1.1.7.1 11728 q Dry hair PD-1.1.10.5 11783
q Amputated hand PD-1.1.7.2 11729 q Fine hair PD-1.1.10.6 11784
q Amputated leg PD-1.1.7.3 11730 q Follicular hyperkeratosis PD-1.1.10.7 11785
q Athetoid movement PD-1.1.7.4 11731 q Hair changes due to malnutrition PD-1.1.10.8 11786
q Decreased range of ankle movement PD-1.1.7.5 11732 q Hair lacks luster PD-1.1.10.9 11787
q Decreased range of cervical spine movement PD-1.1.7.6 11733 q Hypertrichosis PD-1.1.10.10 11788
q Decreased range of elbow movement PD-1.1.7.7 11734 q Increased loss of hair PD-1.1.10.11 11789
q Decreased range of finger movement PD-1.1.7.8 11735 q Nutritional hair color change PD-1.1.10.12 11790
q Decreased range of foot movement PD-1.1.7.9 11736 q White hair PD-1.1.10.13 11791
q Decreased range of hip movement PD-1.1.7.10 11737 q Head (11)
q Decreased range of knee movement PD-1.1.7.11 11738 q Altered olfactory sense PD-1.1.11.1 11793
q Decreased range of lumbar spine movement PD-1.1.7.12 11739 q Anosmia PD-1.1.11.2 11794
q Decreased range of shoulder movement PD-1.1.7.13 11740 q Bulging fontanelle PD-1.1.11.3 11795
q Decreased range of subtalar movement PD-1.1.7.14 11741 q Epistaxis PD-1.1.11.4 11796
q Decreased range of thumb movement PD-1.1.7.15 11742 q Headache PD-1.1.11.5 11797
q Decreased range of toe movement PD-1.1.7.16 11743 q Hyposmia PD-1.1.11.6 11798
q Decreased range of thoracic spine movement PD-1.1.7.17 11744 q Macrocephaly PD-1.1.11.7 11799
q Decreased range of wrist movement PD-1.1.7.18 11745 q Microcephaly PD-1.1.11.8 11800
q Hypertonia PD-1.1.7.19 11746 q Nasal mucosa dry PD-1.1.11.9 11801
q Hypotonia PD-1.1.7.20 11747 q Sunken fontanelle PD-1.1.11.10 11802
7
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Hand and nails (12) q Neck (15)
q Beau’s lines PD-1.1.12.1 11804 q Goiter PD-1.1.15.1 11859
q Clubbing of nails PD-1.1.12.2 11805 q Nerves, cognition, and feelings (16)
q Flaking of nails PD-1.1.12.3 11806 q Abnormal gait PD-1.1.16.1 11860
q Koilonychia PD-1.1.12.4 11807 q Absent reflex PD-1.1.16.2 11861
q Leukonychia PD-1.1.12.5 11808 q Asterixis PD-1.1.16.3 11862
q Longitudinal grooving of nails PD-1.1.12.6 11809 q Ataxia PD-1.1.16.4 11863
q Muehrcke’s lines PD-1.1.12.7 11810 q Clouded consciousness PD-1.1.16.5 11864
q Nail changes PD-1.1.12.8 11811 q Cranial nerve finding PD-1.1.16.6 11865
q Palmer erythema PD-1.1.12.9 11812 q Decreased vibratory sense PD-1.1.16.7 11866
q Ridged nails PD-1.1.12.10 11813 q Delirious PD-1.1.16.8 11867
q Splits in nails PD-1.1.12.11 11814 q Dementia PD-1.1.16.9 11868
q Thin nails PD-1.1.12.12 11815 q Depressed mood PD-1.1.16.10 11869
q Trachyonychia PD-1.1.12.13 11816 q Disoriented PD-1.1.16.11 11870
q Splinter hemorrhage under nails PD-1.1.12.14 11817 q Dizziness PD-1.1.16.12 11871
q White flecks in nails PD-1.1.12.15 11818 q Feels cold PD-1.1.16.13 11872
q Mouth (13) q Flat affect PD-1.1.16.14 11873
q Ageusia PD-1.1.13.1 11820 q Hyperreflexia PD-1.1.16.15 11874
q Angular stomatitis PD-1.1.13.2 11821 q Hyporeflexia PD-1.1.16.16 11875
q Aphthous ulcer of mouth PD-1.1.13.3 11822 q Inappropriate affect PD-1.1.16.17 11876
q Aptyalism PD-1.1.13.4 11823 q Many seizures a day PD-1.1.16.18 11877
q Blue lips PD-1.1.13.5 11824 q Numbness of foot PD-1.1.16.19 11878
q Blue line on gingiva PD-1.1.13.6 11825 q Numbness of hand PD-1.1.16.20 11879
q Candidiasis of the mouth PD-1.1.13.7 11826 q Peripheral nerve disease PD-1.1.16.21 11880
q Cheilosis PD-1.1.13.8 11827 q Tremor of outstretched hand PD-1.1.16.22 11881
q Cheilitis PD-1.1.13.9 11828 q Tingling of foot PD-1.1.16.23 11882
q Cleft palate PD-1.1.13.10 11829 q Tingling of hand PD-1.1.16.24 11883
q Cracked lips PD-1.1.13.11 11830 q Skin (17)
q Drooling PD-1.1.13.12 11831 q Acanthosis nigricans PD-1.1.17.1 11884
q Dry mucus membranes PD-1.1.13.13 11832 q Calcinosis PD-1.1.17.2 11885
q Dysgeusia PD-1.1.13.14 11833 q Carotenemia PD-1.1.17.3 11886
q Excessive salivation PD-1.1.13.15 11834 q Cutaneous xanthoma PD-1.1.17.4 11887
q Excessive thirst PD-1.1.13.16 11835 q Decreased skin turgor PD-1.1.17.5 11888
q Gingival hypertrophy PD-1.1.13.17 11836 q Dermatitis PD-1.1.17.6 11889
q Gingivitis PD-1.1.13.18 11837 q Diaper rash PD-1.1.17.7 11890
q Halitosis PD-1.1.13.19 11838 q Dry skin PD-1.1.17.8 11891
q Hemorrhagic gingivitis PD-1.1.13.20 11839 q Ecchymosis PD-1.1.17.9 11892
q Hypogeusia PD-1.1.13.21 11840 q Erythema PD-1.1.17.10 11893
q Ketotic breath PD-1.1.13.22 11841 q Eczema PD-1.1.17.11 11894
q Micrognathia PD-1.1.13.23 11842 q Flushing PD-1.1.17.12 11895
q Swollen gums PD-1.1.13.24 11843 q Hirsutism PD-1.1.17.13 11896
q Oral candidiasis PD-1.1.13.25 11844 q Hyperpigmentation of skin PD-1.1.17.14 11897
q Oral lesion PD-1.1.13.26 11845 q Impaired skin integrity PD-1.1.17.15 11898
q Parotid swelling PD-1.1.13.27 11846 q Jaundice PD-1.1.17.16 11899
q Poor oral hygiene PD-1.1.13.28 11847 q Keratinization of skin PD-1.1.17.17 11900
q Retains food in mouth PD-1.1.13.29 11848 q Pale complexion PD-1.1.17.18 11901
q Stomatitis PD-1.1.13.30 11849 q Peeling skin PD-1.1.17.19 11902
q Uremic breath PD-1.1.13.31 11850 q Petechiae PD-1.1.17.20 11903
q Muscles (14) q Impaired wound healing PD-1.1.17.21 11904
Muscle atrophy PD-1.1.14.1 11852 q Pressure injury of ankles PD-1.1.17.22 11905
Muscle contracture PD-1.1.14.2 11853 q Pressure injury of back PD-1.1.17.23 11906
Muscle cramp PD-1.1.14.3 11854 q Pressure injury of breast PD-1.1.17.24 11907
Muscle pain PD-1.1.14.4 11855 q Pressure injury of buttock PD-1.1.17.25 11908
Muscle weakness PD-1.1.14.5 11856 q Pressure injury of dorsum of foot PD-1.1.17.26 11909
Quadriceps muscle wasting PD-1.1.14.6 11857 q Pressure injury of elbow PD-1.1.17.27 11910
8
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Pressure injury of head PD-1.1.17.28 11911 q Lesion of the tongue PD-1.1.20.8 11966
q Pressure injury of heel PD-1.1.17.29 11912 q Strawberry tongue PD-1.1.20.9 11967
q Pressure injury of hip PD-1.1.17.30 11913 q Macroglossia PD-1.1.20.10 11968
q Pressure injury of knee PD-1.1.17.31 11914 q Short frenulum of tongue PD-1.1.20.11 11969
q Pressure injury of natal cleft PD-1.1.17.32 11915 q Split frenulum of tongue PD-1.1.20.12 11970
q Pressure injury of shoulder PD-1.1.17.33 11916 q Vital signs PD-1.1.21 10370
q Pressure injury stage 1 PD-1.1.17.34 11917
q Pressure injury stage 2 PD-1.1.17.35 11918 CLIENT HISTORY (CH)
q Pressure injury stage 3 PD-1.1.17.36 11919 Current and past information related to personal, medical, family, and social history.
q Pressure injury stage 4 PD-1.1.17.37 11920
Personal History (1)
q Pruritus of the skin PD-1.1.17.38 11921
General patient/client information such as age, gender, sex, race, ethnicity, language,
q Psoriasis PD-1.1.17.39 11922 education, and role in family.
q Scaling skin PD-1.1.17.40 11923 Personal data (1.1)
q Seborrheic dermatitis PD-1.1.17.41 11924 q Age CH-1.1.1 10374
q Skin rash PD-1.1.17.42 11925 q Gender CH-1.1.2 10375
q Stasis ulcer PD-1.1.17.43 11926 q Sex CH-1.1.3 11138
q Yellow skin PD-1.1.17.44 11927 q Race CH-1.1.4 11139
q Teeth (18) q Ethnicity CH-1.1.5 11140
q Baby bottle tooth decay PD-1.1.18.1 11929 q Language CH-1.1.6 10377
q Broken denture PD-1.1.18.2 11930 q Literacy factors CH-1.1.7 10378
q Broken teeth PD-1.1.18.3 11931 q Education CH-1.1.8 10379
q Dental caries PD-1.1.18.4 11932 q Role in family CH-1.1.9 10380
q Dental fluorosis PD-1.1.18.5 11933 q Tobacco use CH-1.1.10 10381
q Dental plaque PD-1.1.18.6 11934 q Physical disability CH-1.1.11 10382
q Denture loose PD-1.1.18.7 11935 q Mobility CH-1.1.12 10383
q Denture lost PD-1.1.18.8 11936 Patient/Client/Family Medical/Health History (2)
q Denture present PD-1.1.18.9 11937 Patient/client or family disease states, conditions, and illnesses that may have nutritional
q Edentulous PD-1.1.18.10 11938 impact.
q Erosion of teeth PD-1.1.18.11 11939 Patient/client OR family nutrition-oriented medical/health history (2.1)
q Impaired dentition PD-1.1.18.12 11940 Specify issue(s) and whether it is patient/client history (P) or family history (F)
q Ill fitting denture PD-1.1.18.13 11941 q Patient/client chief nutrition complaint CH-2.1.1 10386
q Mottling of enamel PD-1.1.18.14 11942 (specify) __________________________ P or F
q Partially edentulous mandible PD-1.1.18.15 11943 q Cardiovascular CH-2.1.2 10387
q Partially edentulous maxilla PD-1.1.18.16 11944 (specify) __________________________ P or F
q Rampant dental caries PD-1.1.18.17 11945 q Endocrine/metabolism CH-2.1.3 10388
q Throat and swallowing (19) (specify) __________________________ P or F
q Choking during swallowing PD-1.1.19.1 11947 q Excretory CH-2.1.4 10389
q Cough PD-1.1.19.2 11948 (specify) __________________________ P or F
q Dysphagia PD-1.1.19.3 11949 q Gastrointestinal CH-2.1.5 10390
q Esophageal lesion PD-1.1.19.4 11950 (specify) __________________________ P or F
q Food sticks on swallowing PD-1.1.19.5 11951 q Gynecological CH-2.1.6 10391
q Gagging PD-1.1.19.6 11952 (specify) __________________________ P or F
q Hoarse voice PD-1.1.19.7 11953 q Hematology/oncology CH-2.1.7 10392
q Hypoactive gag reflex PD-1.1.19.8 11954 (specify) __________________________ P or F
q Odynophagia PD-1.1.19.9 11955 q Immune (e.g., food allergies) CH-2.1.8 10393
q Swallow impairment PD-1.1.19.10 11956 (specify) __________________________ P or F
q Suck, swallow, breath incoordination PD-1.1.19.11 11957 q Integumentary CH-2.1.9 10394
q Tongue (20) (specify) __________________________ P or F
q Atrophy of tongue papillae PD-1.1.20.1 11959 q Musculoskeletal CH-2.1.10 10395
q Beefy red tongue PD-1.1.20.2 11960 (specify) __________________________ P or F
q Difficulty moving tongue PD-1.1.20.3 11961 q Neurological CH-2.1.11 10396
q Dry tongue PD-1.1.20.4 11962 (specify) __________________________ P or F
q Glossitis PD-1.1.20.5 11963 q Psychological CH-2.1.12 10397
q Glossodynia PD-1.1.20.6 11964 (specify) __________________________ P or F
q Hypertrophy of tongue papillae PD-1.1.20.7 11965
9
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.
 Nutrition Assessment and Monitoring and Evaluation Terminology
NCPT Code ANDUID NCPT Code ANDUID
 
q Respiratory CH-2.1.13 10398 Estimated fiber needs (2.4)
(specify) __________________________ P or F q Total fiber estimated needs CS-2.4.1 10435
q Other CH-2.1.14 10399 q Type of fiber needed CS-2.4.2 10436
(specify) __________________________ P or F q Method for estimating needs CS-2.4.3 10437
Treatments/therapy (2.2)
Fluid Needs (3)
Documented medical or surgical treatments that may impact nutritional status of the
patient Estimated fluid needs (3.1)
q Medical treatment/therapy CH-2.2.1 10401 q Total fluid estimated needs CS-3.1.1 10440
(specify) _______________________________ q Method for estimating needs CS-3.1.2 10441
q Surgical treatment CH-2.2.2 10402 Micronutrient Needs (4)
(specify) _______________________________ Estimated vitamin needs (4.1)
q Palliative/end-of-life care CH-2.2.3 10404 q A (1) 10444
(specify) _______________________________ q C (2) 10445
Social History (3) q D (3) 10446
Patient/client socioeconomic status, housing situation, medical support, and involvement
q E (4) 10447
in social groups.
q K (5) 10448
Social history (3.1)
q Socioeconomic factors CH-3.1.1 10407 q Thiamin (6) 10449

(specify) _______________________________ q Riboflavin (7) 10450

q Living/housing situation CH-3.1.2 10408 q Niacin (8) 10451

(specify) _______________________________ q Folate (9) 10452
q Domestic issues CH-3.1.3 10409 q B6 (10) 10453
(specify) _______________________________ q B12 (11) 10454
q Social and medical support CH-3.1.4 10410
q Pantothenic acid (12) 10455
(specify) _______________________________
q Biotin (13) 10456
q Geographic location of home CH-3.1.5 10411
q Method for estimating needs (14) 10458
(specify) _______________________________
q Occupation CH-3.1.6 10412
Estimated mineral needs (4.2)

(specify) _______________________________ q Calcium (1) 10460

q Religion CH-3.1.7 10413 q Chloride (2) 10461

(specify) _______________________________ q Iron (3) 10462
q History of recent crisis CH-3.1.8 10414 q Magnesium (4) 10463
(specify) _______________________________ q Potassium (5) 10464
q Daily stress level CH-3.1.9 10415
q Phosphorus (6) 10465
(specify) _______________________________
q Sodium (7) 10466
q Zinc (8) 10467
COMPARATIVE STANDARDS (CS)
q Sulfate (9) 10469
Energy Needs (1)
q Fluoride (10) 10470
Estimated energy needs (1.1)
q Copper (11) 10471
q Total energy estimated needs CS-1.1.1 10419
q Method for estimating needs CS-1.1.2 10420 q Iodine (12) 10473

Macronutrient Needs (2) q Selenium (13) 10474

Estimated fat needs (2.1) q Manganese (14) 10475

q Total fat estimated needs CS-2.1.1 10423 q Chromium (15) 10476

q Type of fat needed CS-2.1.2 10424 q Molybdenum (16) 10477

q Method for estimating needs CS-2.1.3 10425 q Boron (17) 10478

Estimated protein needs (2.2) q Cobalt (18) 10479
q Total protein estimated needs CS-2.2.1 10427 q Method for estimating needs (19) 10480
q Type of protein needed CS-2.2.2 10428 Weight and Growth Recommendation (5)
q Method for estimating needs CS-2.2.3 10429 Recommended body weight/body mass Index/growth (5.1)
Estimated carbohydrate needs (2.3) q Ideal/reference body weight (IBW) CS-5.1.1 10483
q Total carbohydrate estimated needs CS-2.3.1 10431 q Recommended body mass index (BMI) CS-5.1.2 10484
q Type of carbohydrate needed CS-2.3.2 10432 q Desired growth pattern CS-5.1.3 10485
q Method for estimating needs CS-2.3.3 10433
 
10
Nutrition Care Process Terminology (eNCPT), 2015 Edition. Copyright 2015 Academy of Nutrition and Dietetics.